{"method": [[" Eleven PD patients with generalized SAD and 21 PD patients without SAD were included in this study; groups were matched for age, gender, disease duration and disease severity.", {"pattern": {"sp_index": 1424, "sub": ["PD", "patients"], "pred": ["were", "included"], "nes": {"SAD": 2}, "cds": {"patients": 1}}, "sp": 1, "ne": 4, "cd": 126, "sid": "5", "total": 131, "doc_id": "./anns_v2/Moriyama et al., (2011) - Increased dopamine transported density in PD with SAD_annotated_ann.json"}], [" Tiihonen et al. found [15] lower DAT density in 11 SAD patients when compared with 28 matched controls; Schneider et al. [13] studied dopamine D2 receptor availability in non- medicated SAD patients and found it to be decreased in relation to controls.", {"pattern": {"sp_index": -1, "sub": ["Tiihonen", "al."], "pred": ["found"], "nes": {"Tiihonen": 1, "DAT": 1}, "cds": {"patients": 1, "]": 2, "controls": 1}}, "sp": 0, "ne": 3, "cd": 140, "sid": "55", "total": 143, "doc_id": "./anns_v2/Moriyama et al., (2011) - Increased dopamine transported density in PD with SAD_annotated_ann.json"}]], "findings": [["In our study we found no mean differences for DAT BP values in different striatal regions between SAD and non-SAD participants but the intensity of social anxiety symptoms was positively and significantly correlated to DAT density in the right putamen and left caudate and putamen.", {"pattern": {"sp_index": 14, "sub": ["we"], "pred": ["found"], "nes": {"DAT": 2, "SAD": 1}, "cds": {}}, "sp": 5, "ne": 7, "cd": 0, "sid": "52", "total": 12, "doc_id": "./anns_v2/Moriyama et al., (2011) - Increased dopamine transported density in PD with SAD_annotated_ann.json"}], ["We found intensity of social anxiety symptoms to be correlated with increased DAT density in PD patients.", {"pattern": {"sp_index": 3, "sub": ["We"], "pred": ["found"], "nes": {"DAT": 1}, "cds": {}}, "sp": 9, "ne": 3, "cd": 0, "sid": "85", "total": 12, "doc_id": "./anns_v2/Moriyama et al., (2011) - Increased dopamine transported density in PD with SAD_annotated_ann.json"}]], "goal": [[" The aim of this study was to investigate a possible dopaminergic mechanism involved in PD patients with SAD, by correlating striatal dopamine transporter binding potential (DAT-BP) with intensity of social anxiety symptoms in PD patients using SPECT with TRODAT-1 as the radiopharmaceutical.", {"pattern": {"sp_index": 0, "sub": ["aim"], "pred": ["was"], "nes": {"SPECT": 1, "SAD": 1}, "cds": {}}, "sp": 14, "ne": 15, "cd": 0, "sid": "4", "total": 29, "doc_id": "./anns_v2/Moriyama et al., (2011) - Increased dopamine transported density in PD with SAD_annotated_ann.json"}], [" The aim of our study was to investigate a possible dopaminergic mechanism involved in PD patients with SAD, by correlating striatal DAT density with social anxiety symptom intensity in PD patients using TRODAT-1 as the radiopharmaceutical.", {"pattern": {"sp_index": 0, "sub": ["aim"], "pred": ["was"], "nes": {"DAT": 1, "SAD": 1}, "cds": {}}, "sp": 14, "ne": 7, "cd": 0, "sid": "21", "total": 21, "doc_id": "./anns_v2/Moriyama et al., (2011) - Increased dopamine transported density in PD with SAD_annotated_ann.json"}]]}